Agricultural Groups Weigh In on Supreme Court case for biotech alfalfa.

Press Release Summary:



US Supreme Court will decide if lower court acted hastily and incorrectly by banning cultivation of biotech alfalfa despite evidence documenting its safety. On March 8, coalition of agricultural organizations filed joint friend-of-the-court brief to Supreme Court in support of petitioners in Monsanto Co. v. Geertson Seed Farms. Groups urge that the lower court's decision to approve injunction without adequately hearing key evidence must be reversed for benefit of farmer and consumer.



Original Press Release:



Ag Groups Weigh-in on Supreme Court Case for Biotech Alfalfa



WASHINGTON, D.C. - The U.S. Supreme Court will decide whether a lower court acted hastily and incorrectly by banning the cultivation of biotech alfalfa despite extensive scientific evidence documenting the safety of the crop. A coalition of agricultural organizations filed on March 8 a joint friend-of-the-court brief to the Supreme Court in support of the petitioners in "Monsanto Co. v. Geertson Seed Farms."

The brief was submitted by the American Farm Bureau Federation, Biotechnology Industry Organization, American Seed Trade Association, American Soybean Association, National Alfalfa and Forage Alliance, National Association of Wheat Growers, National Cotton Council and National Potato Council.

The groups urge that the lower courts' decision to approve an injunction without adequately hearing the key evidence must be reversed "to protect the farmers who choose to grow genetically-engineered crops, as well as the public benefits that agricultural biotechnology brings to producers and consumers around the world."

In the lower court case, environmental groups and individual organic alfalfa farmers sued the United States Department of Agriculture (USDA), claiming that USDA's decision to grant deregulated status to glyphosate-tolerant (or "Roundup Ready®") alfalfa violated the National Environmental Policy Act.

The courts in the Ninth Circuit determined that USDA should have done an environmental impact statement (EIS) before it decided to deregulate, and the court ultimately enjoined almost all planting and sale of Roundup Ready® alfalfa pending the issuance of the EIS.

The lower court's injunction against biotech alfalfa, however, was made without the court conducting a thorough review of evidence that precluded a finding of irreparable harm, according to the brief. In addition, the brief explains that the lower courts failed to consider the public benefits of agricultural biotechnology, which already is adopted widely in the United States for a number of key crops such as corn, soybeans, cotton, sugar beets, and papaya.

In 2005, USDA'S Animal and Plant Health Inspection Service (APHIS) concluded that there is no significant impact on the human environment due to granting non-regulated status to Roundup Ready® alfalfa. Following the lower court's ruling, APHIS completed a 1,400-page document as its draft EIS, and again has recommended that Roundup Ready® alfalfa be deregulated and that farmers be allowed to grow it.

This is an important case because it will be the first time the high court has weighed in on the risks of genetically engineered crops. Of the more than 10,000 cases appealed to the Supreme Court each year, only about 1 percent is accepted for review on the merits and oral arguments. This matter is scheduled for oral argument on April 27. A decision is expected from the Court by June.

Upcoming BIO Events

BIO-Europe Spring
March 8-10, 2010
Barcelona, Spain

BIO Intellectual Property Counsels Spring Conference and Committee Meeting
April 19-21, 2010
New Orleans, LA

Partnering for Global Health
May 3, 2010
Chicago, IL
McCormick Place Convention Center

BIO International Convention
May 3-6, 2010
Chicago, IL
McCormick Place Convention Center

2010 BIO Human Resources Conference
May 4-7, 2010
Chicago, IL

World Congress on Industrial Biotechnology and Bioprocessing
June 27-30, 2010
Washington, DC

BIO's Livestock Biotechnology Summit
September 28-30, 2010,
Sioux Falls, SD

About BIO

BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.

All Topics